Kurkijarvi Kalevi 4
4 · FIBROGEN INC · Filed Jan 15, 2021
Insider Transaction Report
Form 4
FIBROGEN INCFGEN
Kurkijarvi Kalevi
Director
Transactions
- Exercise/Conversion
Common Stock
2021-01-14$19.05/sh+5,999$114,281→ 39,099 total - Exercise/Conversion
Stock Option (Right to Buy)
2021-01-14−5,999→ 6,000 totalExercise: $19.05Exp: 2026-06-08→ Common Stock (5,999 underlying) - Sale
Common Stock
2021-01-14$40.04/sh−5,999$240,200→ 33,100 total
Footnotes (3)
- [F1]Shares sold pursuant to a 10b5-1 plan.
- [F2]The shares were sold at prices ranging from $40.00 to $40.07. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F3]Fully vested.